Publication | Closed Access

Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge

AntibioticsMedicineEarly Hospital DischargeHealthcare-associated InfectionPharmacotherapyAntimicrobial ChemotherapyCancer PatientsOncologyOral MoxifloxacinHospital Medicine